These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9470201)

  • 21. [Struggle about the best reducing diet, Fat gone by means of more fat?].
    Bischoff A
    MMW Fortschr Med; 2004 Jan; 146(1-2):4-6. PubMed ID: 18441569
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention and management of obesity: pharmacology .
    Finer N
    Proc Nutr Soc; 2000 Aug; 59(3):413. PubMed ID: 10997657
    [No Abstract]   [Full Text] [Related]  

  • 23. Sibutramine for obesity.
    Med Lett Drugs Ther; 1998 Mar; 40(1022):32. PubMed ID: 9529518
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug therapy for management of obesity.
    Heine RJ
    Lancet; 2001 Apr; 357(9264):1287-8. PubMed ID: 11421206
    [No Abstract]   [Full Text] [Related]  

  • 25. Sibutramine in the management of obesity.
    Brunton S
    J Fam Pract; 2003 Aug; 52(8):635. PubMed ID: 12899819
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sibutramine lost and found.
    Bosello O; Carruba MO; Ferrannini E; Rotella CM
    Eat Weight Disord; 2002 Sep; 7(3):161-7. PubMed ID: 12452247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valuable lessons from research on drugs for adolescent obesity in Mexico.
    Bastarrachea RA; López-Alvarenga J; Calzada-León R; Arellano-Montaño S; Gonzalez-Barranco J
    Adv Ther; 2006; 23(3):506-7; author reply 507-9. PubMed ID: 16989042
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk factor modification through weight loss enhanced with pharmacotherapy.
    Eisenberg D
    Curr Atheroscler Rep; 2002 Jan; 4(1):51. PubMed ID: 11772422
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic agents for the treatment of obesity.
    Mathys M
    Clin Geriatr Med; 2005 Nov; 21(4):735-46, vii. PubMed ID: 16182086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for obesity--promise and uncertainty.
    Yanovski SZ
    N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure].
    Astrup A
    Acta Med Austriaca; 1998; 25(4-5):146-9. PubMed ID: 9879391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [No progress without the physician in therapy of obesity].
    Schmidt H; Plauth M
    MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of sibutramine.
    Lieberman JA
    J Fam Pract; 2002 Oct; 51(10):863; author reply 863, 867. PubMed ID: 12401157
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of obesity in practice - more necessary than ever].
    Wirth A
    Dtsch Med Wochenschr; 2002 Mar; 127(12):605. PubMed ID: 11907861
    [No Abstract]   [Full Text] [Related]  

  • 36. [What effect does losing weight have on hypertension?].
    Engeli S
    MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
    [No Abstract]   [Full Text] [Related]  

  • 37. [Weight reduction. Doubly effective with drug support].
    MMW Fortschr Med; 2001 Apr; 143(15):42-3. PubMed ID: 11349320
    [No Abstract]   [Full Text] [Related]  

  • 38. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.